Terms: = Gastric cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
197 results:
1. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Groen-van Schooten TS; Harrasser M; Seidel J; Bos EN; Fleitas T; van Mourik M; Pouw RE; Goedegebuure RSA; Doeve BH; Sanders J; Bos J; van Berge Henegouwen MI; Thijssen VLJL; van Grieken NCT; van Laarhoven HWM; de Gruijl TD; Derks S
Front Immunol; 2024; 15():1372272. PubMed ID: 38638445
[TBL] [Abstract] [Full Text] [Related]
2. TOB1 modulates neutrophil phenotypes to influence gastric cancer progression and immunotherapy efficacy.
Zhang J; Li Y; Chen J; Huang T; Lin J; Pi Y; Hao H; Wang D; Liang X; Fu S; Yu J
Front Immunol; 2024; 15():1369087. PubMed ID: 38617839
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
Papadakos KS; Gorji-Bahri G; Gialeli C; Hedner C; Hagerling C; Svensson MC; Jeremiasen M; Borg D; Fristedt R; Jirström K; Blom AM
Cancer Immunol Immunother; 2024 Apr; 73(5):93. PubMed ID: 38563861
[TBL] [Abstract] [Full Text] [Related]
4. Increased infiltration of CD4
Guo Y; Chen J; Huang Y; Ke S; Xie F; Li D; Li B; Lu H
Eur J Immunol; 2024 Mar; 54(3):e2350662. PubMed ID: 38366919
[TBL] [Abstract] [Full Text] [Related]
5. Potential gastric cancer Immunotherapy: Stimulating the Immune System with
Afkhamipour M; Kaviani F; Dalali S; Piri-Gharaghie T; Doosti A
Arch Immunol Ther Exp (Warsz); 2024 Jan; 72(1):. PubMed ID: 38346161
[TBL] [Abstract] [Full Text] [Related]
6. Neoadjuvant chemotherapy is linked to an amended anti-tumorigenic microenvironment in gastric cancer.
Huan X; Zou K; Zhang P; Ding H; Luo C; Xiang C; Xu S; Zhuang Y; Wu C; Wang Y; Wu X; Chen C; Zhang J; Yao X; Liu F; Liu S; Wu Z
Int Immunopharmacol; 2024 Jan; 127():111352. PubMed ID: 38091833
[TBL] [Abstract] [Full Text] [Related]
7. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment.
Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475
[TBL] [Abstract] [Full Text] [Related]
8. Expression characteristics of peripheral lymphocyte programmed death 1 and foxp3
Li H; Cao GM; Gu GL; Li SY; Yan Y; Fu Z; Du XH
World J Gastroenterol; 2023 Oct; 29(40):5582-5592. PubMed ID: 37970473
[TBL] [Abstract] [Full Text] [Related]
9. Coding RNA expression profile and transcription factor analysis of H.pylori-associated chronic atrophic gastritis.
Wang X; Dong J; Sheng H; Ma X; Baheti L; Xu J
Adv Med Sci; 2023 Sep; 68(2):491-498. PubMed ID: 37945439
[TBL] [Abstract] [Full Text] [Related]
10. [Study of immunophenotypic characteristics, clinicopathological parameters and prognosis in gastric cancer microenvironment].
Wu Y; Chen YQ; Shi TG; Tan NJ; Chen WC
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2786-2794. PubMed ID: 37723053
[No Abstract] [Full Text] [Related]
11. Effect of sevoflurane on CD4+CD25+foxp3+ regulatory T cells in patients with gastric cancer undergoing radical surgery.
Yong F; Wang H; Li C; Liu W; Wang Z; Jia H
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):214-220. PubMed ID: 37715379
[TBL] [Abstract] [Full Text] [Related]
12. Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse gastric Carcinogenesis.
Green BL; Gamble LA; Diggs LP; Nousome D; Patterson JC; Joughin BA; Gasmi B; Lux SC; Samaranayake SG; Miettinen M; Quezado M; Hernandez JM; Yaffe MB; Davis JL
Mol Cancer Res; 2023 Dec; 21(12):1356-1365. PubMed ID: 37707375
[TBL] [Abstract] [Full Text] [Related]
13. CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer.
Xu D; Liu X; Ke S; Guo Y; Zhu C; Cao H
BMC Cancer; 2023 May; 23(1):464. PubMed ID: 37208608
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic Value of T-Cell Density in the Tumor Center and Outer Margins in gastric cancer.
Soeratram TTD; Biesma HD; Egthuijsen JMP; Meershoek-Klein Kranenbarg E; Hartgrink HH; van de Velde CJH; Mookhoek A; van Dijk E; Kim Y; Ylstra B; van Laarhoven HWM; van Grieken NCT
Mod Pathol; 2023 Sep; 36(9):100218. PubMed ID: 37182582
[TBL] [Abstract] [Full Text] [Related]
15. Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer.
Aguinaga-Barrilero A; Juarez I; Vaquero-Yuste C; Molina-Alejandre M; Gutiérrez-Calvo A; Lasa I; López A; Gómez R; Molanes-López EM; Martin-Villa JM
Cell Immunol; 2022 Dec; 382():104635. PubMed ID: 36332356
[TBL] [Abstract] [Full Text] [Related]
16. Regulatory T cells and monocytes crosstalk in patients with gastric cancer.
Poyrazoglu B; Akyildiz H
Ann Ital Chir; 2022; 93():544-549. PubMed ID: 36254764
[TBL] [Abstract] [Full Text] [Related]
17. Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment.
Chen Y; Jia K; Sun Y; Zhang C; Li Y; Zhang L; Chen Z; Zhang J; Hu Y; Yuan J; Zhao X; Li Y; Gong J; Dong B; Zhang X; Li J; Shen L
Nat Commun; 2022 Aug; 13(1):4851. PubMed ID: 35982052
[TBL] [Abstract] [Full Text] [Related]
18. Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
Jia K; Chen Y; Sun Y; Hu Y; Jiao L; Ma J; Yuan J; Qi C; Li Y; Gong J; Gao J; Zhang X; Li J; Zhang C; Shen L
BMC Med; 2022 Jul; 20(1):223. PubMed ID: 35811317
[TBL] [Abstract] [Full Text] [Related]
19. Contribution of
Motta-Raymundo A; Rosmaninho P; Santos DF; Ferreira RD; Silva SP; Ferreira C; Sousa AE; Silva SL
Front Immunol; 2022; 13():834137. PubMed ID: 35711410
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of tumor-infiltrating CD163
Kinoshita J; Fushida S; Yamaguchi T; Moriyama H; Saito H; Shimada M; Terai S; Okamoto K; Nakamura K; Ninomiya I; Yagi S; Inaki N
BMC Cancer; 2022 Jun; 22(1):608. PubMed ID: 35658848
[TBL] [Abstract] [Full Text] [Related]
[Next]
